ロード中...
Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model
Dopamine-replacement therapy with L-DOPA is still the gold standard treatment for Parkinson’s disease. One drawback is the common development of L-DOPA-induced dyskinesia (LID) in patients, which can be as disabling as the disease itself. There is no satisfactory adjunct therapy available. Glutamate...
保存先:
| 出版年: | Neurosci Lett |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825183/ https://ncbi.nlm.nih.gov/pubmed/24525249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.02.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|